JPH10279464A5 - - Google Patents
Info
- Publication number
- JPH10279464A5 JPH10279464A5 JP1997099829A JP9982997A JPH10279464A5 JP H10279464 A5 JPH10279464 A5 JP H10279464A5 JP 1997099829 A JP1997099829 A JP 1997099829A JP 9982997 A JP9982997 A JP 9982997A JP H10279464 A5 JPH10279464 A5 JP H10279464A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin preparation
- glycoside
- sesaminol
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Description
【0005】
すなわち、本発明は、次の成分(A)及び(B)
(A)リグナン配糖体である下記の構造式(I)で示されるセサミノール配糖体
(B)抗炎症剤から選ばれる1種又は2種以上
を含有することを特徴とする皮膚外用剤を提供するものである。
【化5】
本発明の好ましい実施態様としては、以下の特徴を有する。
(1)該セサミノール配糖体は、下記の構造式(II−a)、(II−b)もしくは(II−c)で示されるセサミノール配糖体の1種または2種以上を主成分とする。
【化6】
【化7】
【化8】
(2)該セサミノール配糖体は、ゴマ種子やその加湿物もしくは発芽体、またはそれらの粉砕物、またはそれらの脱脂物の含水低級アルコール抽出物である。
(3)該抗炎症剤は、グリチルリチン酸、グリチルレチン酸、メフェナム酸、フェニルブタゾン、インドメタシン、イブプロフェン、ケトプロフェン、アラントイン、グアイアズレン、D−パンテノール及びそれらの誘導体並びにそれらの塩、ε−アミノカプロン酸、酸化亜鉛、ジクロフェナクナトリウム、アロエ抽出物、シコン抽出物、サルビア抽出物、ソウハクヒ抽出物、シソ抽出物、カワラヨモギ抽出物、オランダカラシ抽出物、ガマ抽出物、セイヨウニワトコ抽出物、ヒレハリソウ抽出物、アルニカ抽出物、オウバク抽出物、カミツレ抽出物、シラカバ抽出物、オトギリソウ抽出物、ユーカリ抽出物及びムクロジ抽出物から選ばれる1種または2種以上である。 [0005]
That is, the present invention provides a composition comprising the following components (A) and (B):
(A) Sesaminol glycoside, which is a lignan glycoside, represented by the following structural formula (I):
(B) one or more anti-inflammatory agents
The present invention provides an external skin preparation characterized by comprising:
[C5]
A preferred embodiment of the present invention has the following features.
(1) The sesaminol glycoside contains, as a main component, one or more sesaminol glycosides represented by the following structural formula (II-a), (II-b) or (II-c):
[C6]
[Chemical 7]
[Chemical formula 8]
(2) The sesaminol glycoside is a hydrous lower alcohol extract of sesame seeds, their moistened or germinated products, or their pulverized products, or their defatted products.
(3) The anti-inflammatory agent is one or more selected from glycyrrhizinic acid, glycyrrhetinic acid, mefenamic acid, phenylbutazone, indomethacin, ibuprofen, ketoprofen, allantoin, guaiazulene, D-panthenol and derivatives thereof and salts thereof, ε-aminocaproic acid, zinc oxide, diclofenac sodium, aloe extract, lithospermum root extract, salvia extract, mulberry bark extract, perilla extract, artemisia capillaris extract, watercress extract, cattail extract, elder extract, comfrey extract, arnica extract, phellodendron bark extract, chamomile extract, white birch extract, St. John's wort extract, eucalyptus extract, and soapberry extract.
【0033】
表1の結果に示される如く、本発明品1に代表される高純度リグナン配糖体精製物とグリチルレチン酸を組合せた本発明の組成物および本発明品2に代表される高純度リグナン配糖体精製物とカミツレ抽出物を組合せた本発明の組成物は、これらを皮膚に適用することにより、紫外線による紅斑や色素沈着を効果的に抑制することがわかった。[0033]
As shown in the results in Table 1, it was found that the compositions of the present invention, which combine a high-purity purified lignan glycoside, represented by Invention Product 1, with glycyrrhetinic acid, and the compositions of the present invention , which combine a high-purity purified lignan glycoside, represented by Invention Product 2, with chamomile extract, when applied to the skin, effectively suppress erythema and pigmentation caused by ultraviolet rays.
Claims (4)
(A)リグナン配糖体である下記の構造式(I)で示されるセサミノール配糖体(A) Sesaminol glycoside, which is a lignan glycoside, represented by the following structural formula (I):
(B)抗炎症剤から選ばれる1種又は2種以上(B) one or more anti-inflammatory agents
を含有することを特徴とする皮膚外用剤。A topical skin preparation comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9099829A JPH10279464A (en) | 1997-04-01 | 1997-04-01 | Skin preparation for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9099829A JPH10279464A (en) | 1997-04-01 | 1997-04-01 | Skin preparation for external use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10279464A JPH10279464A (en) | 1998-10-20 |
| JPH10279464A5 true JPH10279464A5 (en) | 2005-03-03 |
Family
ID=14257717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9099829A Pending JPH10279464A (en) | 1997-04-01 | 1997-04-01 | Skin preparation for external use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10279464A (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001031580A (en) * | 1999-05-19 | 2001-02-06 | Kose Corp | External preparation for skin |
| DE10009996B4 (en) * | 2000-03-02 | 2005-10-13 | Cognis Ip Management Gmbh | Solid granules with monodisperse particle size distribution, a process for their preparation and their use |
| JP5218932B2 (en) * | 2001-08-29 | 2013-06-26 | 株式会社富士山 | Zinc-containing lava fine powder cosmetic base material |
| FR2842732B1 (en) * | 2002-07-25 | 2005-06-24 | Oreal | COSMETIC USE OF LIGNANS |
| EP1526832A1 (en) * | 2002-07-25 | 2005-05-04 | L'oreal | Cosmetic use of lignans |
| DE10354380A1 (en) * | 2003-11-20 | 2005-06-16 | Basf Ag | Use of lignans in cosmetic or dermatological preparations |
| JP5789426B2 (en) * | 2011-06-17 | 2015-10-07 | エスエス製薬株式会社 | Epidermis turnover accelerator |
-
1997
- 1997-04-01 JP JP9099829A patent/JPH10279464A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60027455T2 (en) | OLIGOSACCHARIDEALDONIC ACID AND ITS TOPICAL ADMINISTRATION | |
| DE69502147T2 (en) | L-carnitine salt and compositions containing it | |
| US20080138299A1 (en) | Oral Pharmaceuticals or Oral Hygiene Products Comprising Licorice Flavonoid Extract | |
| CA2452326A1 (en) | Topical leave-on compositions containing selected pantothenic acid derivatives | |
| WO1996039130A1 (en) | Terpenoid-type quinones for treatment of diabetes | |
| JP2568288B2 (en) | N-alkoxyalkylamides and cosmetic treatment composition using the same | |
| JPH10279468A5 (en) | ||
| US3275643A (en) | Allantoin-pantothenate compounds | |
| CA2333680A1 (en) | Semi-solid aqueous preparations for oral applications of toltrazuril sulphone | |
| JP2004315386A (en) | Anti-microbial agent | |
| JP2001247469A (en) | Medicine for dental caries and periodontal disease, and composition which contain the medicine and is used for oral cavity, and drink or food containing the medicine | |
| EP0287646A1 (en) | Cosmetic preparations containing ubidecarenones. | |
| EP0302836B1 (en) | Pharmaceutical compositions for topical use containing miocamycin | |
| JPH11255632A (en) | Cosmetic composition | |
| GB977214A (en) | Chemical compounds | |
| EP0447064A2 (en) | Alkyl diamides and cosmetic treating compositions therewith | |
| JP2014058619A (en) | Carboxymethyl chitosan acetate compound, method for producing the same and cosmetic | |
| CN114795988A (en) | Water-soluble salicylic acid and preparation method and application thereof | |
| JPS5545619A (en) | Preventive for dental caries | |
| CN117243842B (en) | A multi-effect oral care composition with excellent taste and its application | |
| KR100551990B1 (en) | Oral composition | |
| JP2000290160A (en) | Bleaching preparation | |
| EP1124816A1 (en) | Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use | |
| JP3340930B2 (en) | Melanin production inhibitor and whitening cosmetic | |
| CN1075498C (en) | New compound and its derivatives and their use |